Skip to main content
SpringerLink
Log in

Tumors of the Pharynx

  • Chapter
  • First Online:
Head and Neck and Endocrine Surgery

  • 1614 Accesses

Abstract

The nasopharynx is the most superior part of the pharynx. It is a vault-shaped dome that acts as a conduit between the nasal cavity and the oropharynx for respiration (Fig. 10.1). It is bounded from all sides by rigid bony structures with little soft tissue overlying, except part of its floor, which is composed of the soft palate. The oropharynx is the middle part of the throat which includes the base of the tongue, the tonsils, the soft palate, and the walls of the pharynx. The hypopharynx is the region between the oropharynx above and the esophageal inlet below.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 149.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 199.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 199.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  1. Yeh S. Histological classification of carcinoma of the nasopharynx with critical review as to as the existence of lymphoepitheliomas. Cancer. 1962;15:895–920.

    Article  CAS  PubMed  Google Scholar 

  2. Shanmugaratnam K, Sobin LH. The World Health Organization histological classification of tumours of the upper respiratory tract and ear. A commentary on the second edition. Cancer. 1993;71:2689–97.

    Article  CAS  PubMed  Google Scholar 

  3. Uhlmann CH, Krueger GR, Sesterhenn K, et al. Nasopharyngeal and adjacent neoplasms. A clinical pathologic and immunologic study. Arch Otorhinolaryngol. 1978;218:163.

    Article  CAS  PubMed  Google Scholar 

  4. Fox R, Graham III WP. Carcinoma of the nasopharynx and posterior pharyngeal wall. Surg Clin North Am. 1986;66(1):97–108.

    CAS  PubMed  Google Scholar 

  5. Lo YMD, Chan LYS, Lo KW, et al. Quantitative analysis of cell-free Epstein-Barr virus DNA in plasma of patients with nasopharyngeal carcinoma. Cancer Res. 1999;59:1188–91.

    CAS  PubMed  Google Scholar 

  6. Chan ATC, Lo YMD, Chan LYS, et al. EBV DNA monitoring during chemotherapy for patients with undifferentiated nasopharyngeal carcinoma: a strong predictor of tumor response. (Abst.) Proc ASCO 2001;20:928.

    Google Scholar 

  7. Lo YMD, Chan LYS, Chan ATC, et al. Quantitative and temporal correlation between circulating cell-free Epstein-Barr virus DNA and tumor recurrence in nasopharyngeal carcinoma. Cancer Res. 1999;59:5452–5.

    CAS  PubMed  Google Scholar 

  8. Xia P, Fu KK, Wong GW, Akazawa C, Verhey LJ. Comparison of treatment plans involving intensity-modulated radiotherapy for nasopharyngeal carcinoma. Int J Radiat Oncol Biol Phys. 2000;48:329–37.

    Article  CAS  PubMed  Google Scholar 

  9. Chan ATC, Teo PML, Leung TWT, et al. A prospective randomized study of chemotherapy adjunctive to definitive radiotherapy in advanced nasopharyngeal carcinoma. Int J Radiat Oncol Biol Phys. 1995;33:569–77.

    Article  CAS  PubMed  Google Scholar 

  10. Rossi A, Molinari R, Boracchi P, et al. Adjuvant chemotherapy with vincristine, cyclophosphamide, and doxorubicin after radiotherapy in local-regional nasopharyngeal cancer: results of a 4-year multicenter randomized study. J Clin Oncol. 1988;6:1401–10.

    CAS  PubMed  Google Scholar 

  11. International Nasopharynx Cancer Study Group. Preliminary results of a randomized trial comparing neoadjuvant chemotherapy (cisplatin, epirubicin, bleomycin) plus radiotherapy vs. radiotherapy alone in stage IV (>N2, M0) undifferentiated nasopharyngeal carcinoma: a positive effect on progression-free survival. Int J Radiat Oncol Biol Phys. 1996;35:463–9.

    Google Scholar 

  12. Chua DTT, Sham JST, Choy D, et al. Preliminary report of the Asian-Oceanian clinical oncology association randomized trial comparing cisplatin and epirubicin followed by radiotherapy versus radiotherapy alone in the treatment of patients with locoregionally advanced nasopharyngeal carcinoma. Cancer. 1998;83:2270–83.

    Article  CAS  PubMed  Google Scholar 

  13. King WWK, Ku PKM, Mok CO, Teo PML. Nasopharyngectomy in the treatment of recurrent nasopharyngeal carcinoma: a twelve-year experience. Head Neck. 2000;22:215–22.

    Article  CAS  PubMed  Google Scholar 

  14. Wei WI, Lam KH, Sham JST. New approach to nasopharynx: the maxillary swing approach. Head Neck. 1991;13:200–7.

    Article  CAS  PubMed  Google Scholar 

  15. To EWH, Teo PML, Ku PKM, Pang PCW. Nasopharyngectomy for recurrent nasopharyngeal carcinoma: an innovative transnasal approach through a mid-face deglove incision with stereotactic navigation guidance. Br J Oral Maxillofac Surg. 2001;39:55–62.

    Article  CAS  PubMed  Google Scholar 

  16. Chan ATC, Teo PML, Leung WT, Johnson PJ. Role of chemotherapy in the management of nasopharyngeal carcinoma. Cancer. 1998;82:1003–12.

    Article  CAS  PubMed  Google Scholar 

  17. Gillison ML, Koch WM, Capone RB, et al. Evidence for a causal association between human papillomavirus and a subset of head and neck cancers. J Natl Cancer Inst. 2000;92:709–20.

    Article  CAS  PubMed  Google Scholar 

  18. Mork J, Lie AK, Glattre E, et al. Human papillomavirus infection as a risk factor for squamous-cell carcinoma of the head and neck. N Engl J Med. 2001;344:1125–31.

    Article  CAS  PubMed  Google Scholar 

  19. D’Souza G, Kreimer AR, Viscidi R, et al. Case-control study of human papillomavirus and oropharyngeal cancer. N Engl J Med. 2007;356:1944–56.

    Article  PubMed  Google Scholar 

  20. Isayeva T, Li Y, Maswahu D, Brandwein-Gensler M. Human papillomavirus in non-oropharyngeal head and neck cancers: a systematic literature review. Head Neck Pathol. 2012;6 Suppl 1:S104–20. doi:10.1007/s12105-012-0368-1.Epub2012Jul3.6.

    Article  PubMed  Google Scholar 

  21. Le QT, Giaccia AJ. Therapeutic exploitation of the physiological and molecular genetic alterations in head and neck cancer. Clin Cancer Res. 2003;9:4287–95.

    CAS  PubMed  Google Scholar 

  22. Fakhry C, Gillison ML. Clinical implications of human papillomavirus in head and neck cancers. J Clin Oncol. 2006;24:2606–11.

    Article  PubMed Central  PubMed  Google Scholar 

  23. Kim ES, Gunn GB, William Jr WN, Kies MS. Chapter 16. Head and neck cancer. In: Kantarjian HM, Wolff RA, Koller CA, editors. The MD Anderson manual of medical oncology. 2nd ed. New York: McGraw-Hill; 2011.

    Google Scholar 

  24. Feng FY, Kim HM, Lyden TH, Haxer HJ, Worden FP, Feng M, et al. Intensity-modulated chemoradiotherapy aiming to reduce dysphagia in patients with oropharyngeal cancer: clinical and functional results. J Clin Oncol. 2010;28(16):2732–8.

    Article  PubMed Central  PubMed  Google Scholar 

  25. Shiley SG, Hargunani CA, Skoner JM, Holland JM, Wax MK. Swallowing function after chemoradiation for advanced stage oropharyngeal cancer. Otolaryngol-Head Neck Surg. 2006;134(3):455–9.

    Article  PubMed  Google Scholar 

  26. Kies MS, Holsinger FC, Lee JJ, William Jr WN, Glisson BS, Lin HY, et al. Induction chemotherapy and cetuximab for locally advanced squamous cell carcinoma of the head and neck: results from a phase II prospective trial. J Clin Oncol. 2010;28(1):8–14.

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  27. Licitra L, Perrone F, Bossi P, et al. High-risk human papillomavirus affects prognosis in patients with surgically treated oropharyngeal squamous cell carcinoma. J Clin Oncol. 2006;24:5630–6.

    Article  CAS  PubMed  Google Scholar 

  28. Weinberger PM, Yu Z, Haffty BG, et al. Molecular classification identifies a subset of human papillomavirus—associated oropharyngeal cancers with favorable prognosis. J Clin Oncol. 2006;24:736–47.

    Article  CAS  PubMed  Google Scholar 

  29. Mellin H, Friesland S, Lewensohn R, et al. Human papillomavirus (HPV) DNA in tonsillar cancer: clinical correlates, risk of relapse, and survival. Int J Cancer. 2000;89:300–4.

    Article  CAS  PubMed  Google Scholar 

  30. Li W, Thompson CH, O’Brien CJ, et al. Human papillomavirus positivity predicts favourable outcome for squamous carcinoma of the tonsil. Int J Cancer. 2003;106:553–8.

    Article  CAS  PubMed  Google Scholar 

  31. Ragin CC, Taioli E. Survival of squamous cell carcinoma of the head and neck in relation to human papillomavirus infection: review and meta-analysis. Int J Cancer. 2007;121:1813–20.

    Article  CAS  PubMed  Google Scholar 

  32. Worden FP, Kumar B, Lee JS, et al. Chemoselection as a strategy for organ preservation in advanced oropharynx cancer: response and survival positively associated with HPV16 copy number. J Clin Oncol. 2008;26:3138–46.

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  33. Fakhry C, Westra WH, Li S, et al. Improved survival of patients with human papillomavirus-positive head and neck squamous cell carcinoma in a prospective clinical trial. J Natl Cancer Inst. 2008;100:261–9.

    Article  CAS  PubMed  Google Scholar 

  34. Pignon JP, Bourhis J, Domenge C, et al. Chemotherapy added to locoregional treatment for head and neck squamous-cell carcinoma: three meta-analyses of updated individual data. MACH-NC Collaborative Group. Meta-Analysis of Chemotherapy on Head and Neck Cancer. Lancet. 2000;355(9208):949–55.

    Article  CAS  PubMed  Google Scholar 

  35. Saleh EM, Abdullwahab AA, Kammal MM. Age and sex incidence of hypopharyngeal tumours in Upper Egypt: Assiut University experience. J Laryngol Otol. 1995;109(8):737–40.

    Article  CAS  PubMed  Google Scholar 

  36. Marchand JL, Luce D, Leclerc A, et al. Laryngeal and hypopharyngeal cancer and occupational exposure to asbestos and man-made vitreous fibers: results of a case-control study. Am J Ind Med. 2000;37(6):581–9.

    Article  CAS  PubMed  Google Scholar 

  37. Takes RP, Strojan P, Silver CE, Bradley PJ, Haigentz Jr M, Wolf GT, et al. Current trends in initial management of hypopharyngeal cancer: the declining use of open surgery. Head Neck. 2012;34(2):270–81.

    Article  PubMed  Google Scholar 

  38. Haddad R, Colevas AD, Tishler R, et al. Docetaxel, cisplatin, and 5-fluorouracil-based induction chemotherapy in patients with locally advanced squamous cell carcinoma of the head and neck: the Dana Farber Cancer Institute experience. Cancer. 2003;97(2):412–8.

    Article  CAS  PubMed  Google Scholar 

  39. Chung EJ, Lee JJ, Kim HS, Lee DJ, Jung CH, Chang YJ, et al. Alternative treatment option for hypopharyngeal cancer: clinical outcomes after conservative laryngeal surgery with partial pharyngectomy. Acta Otolaryngol. 2013;133(8):866–73. doi:10.3109/00016489.2013.785018. Epub 2013 May 6.

    Article  PubMed  Google Scholar 

  40. Garden AS. Organ preservation for carcinoma of the larynx and hypopharynx. Hematol Oncol Clin North Am. 2001;15(2):243–60.

    Article  CAS  PubMed  Google Scholar 

  41. Holsinger FC, Motamed M, Garcia D, et al. Resection of selected invasive squamous cell carcinoma of the pyriform sinus by means of the lateral pharyngotomy approach: the partial lateral pharyngectomy. Head Neck. 2006;28(8):705–11.

    Article  PubMed  Google Scholar 

  42. Ogura JH. “How I do it” – head and neck. A targeted problem and its solution. Hyoid muscle flap reconstruction in subtotal supraglottic laryngectomy: a more rapid rehabilitation of deglutition. Laryngoscope. 1979;89(9 Pt 1):1522–4.

    Article  CAS  PubMed  Google Scholar 

  43. Chevalier D, Watelet JB, Darras JA, et al. Supraglottic hemilaryngopharyngectomy plus radiation for the treatment of early lateral margin and pyriform sinus carcinoma. Head Neck. 1997;19(1):1–5.

    Article  CAS  PubMed  Google Scholar 

  44. Kania R, Hans S, Garcia D, et al. Supracricoid hemilaryngopharyngectomy in patients with invasive squamous cell carcinoma of the pyriform sinus. Part II: incidence and consequences of local recurrence. Ann Otol Rhinol Laryngol. 2005;114(2):95–104.

    Article  PubMed  Google Scholar 

  45. Laccourreye O, Ishoo E, de Mones E, et al. Supracricoid hemilaryngopharyngectomy in patients with invasive squamous cell carcinoma of the pyriform sinus. Part I: technique, complications, and long-term functional outcome. Ann Otol Rhinol Laryngol. 2005;114(1 Pt 1):25–34.

    Article  PubMed  Google Scholar 

  46. Steiner W, Ambrosch P, Hess CF, et al. Organ preservation by transoral laser microsurgery in piriform sinus carcinoma. Otolaryngol Head Neck Surg. 2001;124(1):58–67.

    Article  CAS  PubMed  Google Scholar 

  47. Martin SA, Marks JE, Lee JY, et al. Carcinoma of the pyriform sinus: predictors of TNM relapse and survival. Cancer. 1980;46(9):1974–81.

    Article  CAS  PubMed  Google Scholar 

  48. Hoffman HT, Karnell LH, Shah JP, et al. Hypopharyngeal cancer patient care evaluation. Laryngoscope. 1997;107(8):1005–17.

    Article  CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Head and Neck and Endocrine Surgery, Faculty of Medicine, Alexandria University, Alexandria, Egypt

    Mahmoud Sakr

Authors
  1. Mahmoud Sakr
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Mahmoud Sakr .

Editor information

Editors and Affiliations

  1. Professor of Surgery,Faculty of Medicine, University of Alexandria, Alexandria, Egypt

    Mahmoud Sakr

Rights and permissions

Reprints and permissions

Copyright information

© 2016 Springer International Publishing Switzerland

About this chapter

Cite this chapter

Sakr, M. (2016). Tumors of the Pharynx. In: Sakr, M. (eds) Head and Neck and Endocrine Surgery. Springer, Cham. https://doi.org/10.1007/978-3-319-27532-1_10

Download citation

  • DOI: https://doi.org/10.1007/978-3-319-27532-1_10

  • Published:

  • Publisher Name: Springer, Cham

  • Print ISBN: 978-3-319-27530-7

  • Online ISBN: 978-3-319-27532-1

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics

Search

Navigation